SNP variations and their genetic combination in the COX-2 promoter have been reported to be related to the longitudinal risk of malaria, SMA and all-cause mortality in children living in areas with high Plasmodium falciparum transmission (111). This evidence concerns the gene PTGS2 and malaria.